| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA330: Sofosbuvir for treating chronic hepatitis C |
|
Medicine details |
|
| Medicine name | sofosbuvir (Sovaldi®) |
| Formulation | 200 mg, 400 mg film-coated tablet |
| Reference number | 949 |
| Indication | In combination with other medicinal products for the treatment of chronic hepatitis C in adults |
| Company | Gilead Sciences Ltd |
| BNF chapter | Infections |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 06/01/2014 |
| NICE guidance | |